162 related articles for article (PubMed ID: 34805266)
1. Immunosuppression Induced by Glutamine Deprivation Occurs
Wang L; Xu T; Yang X; Liang Z; Zhang J; Li D; Chen Y; Ma G; Wang Y; Liang Y; Niu H
Front Mol Biosci; 2021; 8():687305. PubMed ID: 34805266
[TBL] [Abstract][Full Text] [Related]
2. Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer.
Ma G; Liang Y; Chen Y; Wang L; Li D; Liang Z; Wang X; Tian D; Yang X; Niu H
Mol Cancer Res; 2020 Feb; 18(2):324-339. PubMed ID: 31672701
[TBL] [Abstract][Full Text] [Related]
3. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells.
Shen X; Jin X; Fang S; Chen J
Cell Mol Biol Lett; 2023 Jul; 28(1):53. PubMed ID: 37420173
[TBL] [Abstract][Full Text] [Related]
4. FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells.
Lee MH; Yanagawa J; Tran L; Walser TC; Bisht B; Fung E; Park SJ; Zeng G; Krysan K; Wallace WD; Paul MK; Girard L; Gao B; Minna JD; Dubinett SM; Lee JM
Am J Transl Res; 2020; 12(2):409-427. PubMed ID: 32194893
[TBL] [Abstract][Full Text] [Related]
5. The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-γ.
Wang L; Yang X; Li D; Liang Z; Chen Y; Ma G; Wang Y; Li Y; Liang Y; Niu H
Onco Targets Ther; 2018; 11():7229-7243. PubMed ID: 30425515
[TBL] [Abstract][Full Text] [Related]
6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
7. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
8. KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma.
Gao Z; Chen JF; Li XG; Shi YH; Tang Z; Liu WR; Zhang X; Huang A; Luo XM; Gao Q; Shi GM; Ke AW; Zhou J; Fan J; Fu XT; Ding ZB
Cancer Cell Int; 2022 Mar; 22(1):128. PubMed ID: 35305624
[TBL] [Abstract][Full Text] [Related]
9. Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression.
Napolitano S; Matrone N; Muddassir AL; Martini G; Sorokin A; De Falco V; Giunta EF; Ciardiello D; Martinelli E; Belli V; Furia M; Kopetz S; Morgillo F; Ciardiello F; Troiani T
J Exp Clin Cancer Res; 2019 Dec; 38(1):492. PubMed ID: 31842958
[TBL] [Abstract][Full Text] [Related]
10. Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathway.
Shen MJ; Xu LJ; Yang L; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
Oncotarget; 2017 Oct; 8(46):80506-80520. PubMed ID: 29113321
[TBL] [Abstract][Full Text] [Related]
11. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
13. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
14. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation.
Ng HY; Li J; Tao L; Lam AK; Chan KW; Ko JMY; Yu VZ; Wong M; Li B; Lung ML
Transl Oncol; 2018 Dec; 11(6):1323-1333. PubMed ID: 30172884
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment.
Yu Y; Liang Y; Li D; Wang L; Liang Z; Chen Y; Ma G; Wu H; Jiao W; Niu H
Cell Death Discov; 2021 Jan; 7(1):15. PubMed ID: 33462221
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
19. Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion
Ma P; Jin X; Fan Z; Wang Z; Yue S; Wu C; Chen S; Wu Y; Chen M; Gu D; Zhang S; Mao R; Fan Y
Cancer Biol Med; 2021 Oct; 19(5):669-84. PubMed ID: 34623791
[TBL] [Abstract][Full Text] [Related]
20. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells.
Shi W; Hou X; Peng H; Zhang L; Li Y; Gu Z; Jiang Q; Shi M; Ji Y; Jiang J
Virol J; 2014 Dec; 11():227. PubMed ID: 25548009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
